ORKA
71.93-1.94 -2.63%Past year
Loading chart…
Loading financials…
Company snapshot
- Ticker
- ORKA
- Exchange
- NGM
- Sector
- Healthcare
- Industry
- Biotechnology
- Market cap
- $4.91B
- Employees
- 68
- Currency
- USD
- Website
- https://orukatx.com
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for…
Latest coverage
Related Other stocks
UnitedHealth Group IncorporatedUNH
J.B. Hunt Transport Services, Inc.JBHT
Zillow Group, Inc.ZG
Opendoor Technologies Inc.OPEN